Cargando…
Interstitial Pneumonitis Secondary to Trastuzumab: A Case Report and Literature Review
Interstitial lung disease is a rare complication of trastuzumab-based breast cancer treatment with few case reports published. Herein, we report the case of a 67-year-old female with early-stage HER2-postitive breast cancer who developed interstitial pneumonitis during cycle 5 of treatment with tras...
Autores principales: | Costa, Ricardo, Costa-Filho, Rubens B., Talamantes, Sarah M., Queiroga Jr, Fernando, Campello, Emmanuel C., Cartaxo, Henrique, Costa, Rubens B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498939/ https://www.ncbi.nlm.nih.gov/pubmed/28690527 http://dx.doi.org/10.1159/000477340 |
Ejemplares similares
-
Trastuzumab-Induced Interstitial Pneumonitis
por: Errisuriz, Kimberly, et al.
Publicado: (2023) -
An Extremely Rapid Case of Pneumonitis with the Use of Nivolumab for Pancreatic Adenocarcinoma
por: Costa, Rubens Barros, et al.
Publicado: (2018) -
Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib
por: Costa, Ricardo, et al.
Publicado: (2014) -
Delayed Paclitaxel-Trastuzumab-Induced Interstitial Pneumonitis in Breast Cancer
por: Abulkhair, Omalkhair, et al.
Publicado: (2011) -
Simultaneous interstitial pneumonitis and cardiomyopathy induced by
venlafaxine
por: Ferreira, Pedro Gonçalo, et al.
Publicado: (2014)